Drug Database
Back to search

Finland· FI-REL-REL62076

BRAVECTO TriUNO

A moksidektiini, yhdistelmävalmisteet product containing fluralaner + moxidectin + pyrantel embonate, registered in Finland by Intervet International B.V.. The same ATC class is registered in 2 of our 19 countries.

ATC QP54AB52

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedBRAVECTO TriUNOATCQP54AB52REGISTER NO.FI-REL-REL62076PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fluralaner + moxidectin + pyrantel embonateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fluralaner + moxidectin + pyrantel embonate is registered in 2 of 19 countries.

Countries holding a registration under ATC QP54AB52 (moksidektiini, yhdistelmävalmisteet), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose
Search fluralaner + moxidectin + pyrantel embonate products by name

Fluralaner + moxidectin + pyrantel embonate · ATC QP54AB52

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Fluralaner + Moxidectin + Pyrantel embonate
Manufacturer
Intervet International B.V.
Country
Finland (FI)
ATC code
QP54AB52
ATC class
Moksidektiini, yhdistelmävalmisteet
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QP54AB52

Moksidektiini, yhdistelmävalmisteet, as other registers publish it.

All fluralaner + moxidectin + pyrantel embonate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0305f8b-3ac6-42c4-a408-bc218ab2a01b
GET /v1/drugs/d0305f8b-3ac6-42c4-a408-bc218ab2a01b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "purutabletti",
  "route": "Suun kautta",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Moksidektiini, yhdistelmävalmisteet",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/24/325/007-009",
  "fimea_rel_id": "REL62076",
  "authorised_at": "2024-11-22"
}
API referenceMCP serverPlans

See everything about fluralaner + moxidectin + pyrantel embonate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console